Cargando…

Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project

OBJECTIVE: To evaluate the specific response of SLE patients to BNT162b2 vaccination and its impact on autoimmunity defined as in vivo production of interferon-alpha (IFNα) by plasmacytoid dendritic cells (pDCs) and autoreactive immune responses. METHODS: Our prospective study included SLE patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mageau, Arthur, Tchen, John, Ferré, Valentine Marie, Nicaise-Roland, Pascale, Descamps, Diane, Delory, Nicole, François, Chrystelle, Mendes, Celine, Papo, Thomas, Goulenok, Tiphaine, Charles, Nicolas, Sacré, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760608/ https://www.ncbi.nlm.nih.gov/pubmed/36563528 http://dx.doi.org/10.1016/j.jaut.2022.102987

Ejemplares similares

Impact du vaccin ARNm BNT162b2 anti-SARS-CoV-2 sur la production d’interféron alpha et l’auto-immunité cellulaire au cours du lupus érythémateux systémique : le projet COVALUS
por: Mageau, A., et al.
Publicado: (2022)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

Autoantibodies against IFNα in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study
por: Beydon, Maxime, et al.
Publicado: (2022)

Risque infectieux et phénotype clinique associée aux auto-anticorps anti-IFNα dans le lupus érythémateux systémique (LES)
por: Bedon, M., et al.
Publicado: (2021)

Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years
por: Mageau, Arthur, et al.
Publicado: (2022)

Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis
por: Dema, Barbara, et al.
Publicado: (2014)

Risque de poussée de lupus érythémateux systémique après un épisode sévère de COVID-19 : analyse de l’Entrepôt de Données de Santé de l’AP–HP
por: Mageau, A., et al.
Publicado: (2022)

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Survie hospitalière après un épisode de COVID-19 sévère chez les patients lupiques : une étude cas-contrôle à l’échelle nationale
por: Mageau, A., et al.
Publicado: (2021)

COVID19 au cours du Lupus Erythémateux systémique : résultats d’une analyse épidémiologique nationale
por: Mageau, A., et al.
Publicado: (2021)

COVID-19 sévère et maladies auto-immunes ou inflammatoires incidentes : une étude épidémiologique nationale à partir des données du PMSI en 2020
por: Helary, A., et al.
Publicado: (2022)

Arterial Thrombotic Events in Adult Inpatients With COVID-19
por: Fournier, Morgane, et al.
Publicado: (2021)

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus
por: Sacre, Karim, et al.
Publicado: (2012)

Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
por: Niebel, Dennis, et al.
Publicado: (2021)

Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study
por: Lariviere, Delphine, et al.
Publicado: (2016)

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus
por: Lenert, Petar S
Publicado: (2006)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
por: Xu, Shu, et al.
Publicado: (2020)

BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
por: Moyon, Quentin, et al.
Publicado: (2022)

Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis
por: Bartels, Lars Erik, et al.
Publicado: (2021)

Failure of receptor revision in the autoreactive B cells in patients with systemic lupus erythematosus
por: Yoshikawa, H, et al.
Publicado: (2003)

New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus
por: Battesti, Gilles, et al.
Publicado: (2020)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Autoreactive T cells to histone H1 and core histones in patients with systemic lupus erythematosus
por: Stummvoll, GH, et al.
Publicado: (2005)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
por: Ko, Geon Young, et al.
Publicado: (2023)

Life-Threatening Hypercalcemia Revealing Diffuse and Isolated Acute Sarcoid-Like Myositis: A New Entity? (A Case-Series)
por: Mageau, Arthur, et al.
Publicado: (2016)

New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
por: Hidaka, Daisuke, et al.
Publicado: (2021)

Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus
por: Jin, Ou, et al.
Publicado: (2010)

Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus
por: Sisirak, Vanja, et al.
Publicado: (2014)

Induction of autoreactive B cells allows priming of autoreactive T cells
Publicado: (1991)

Diversity, cellular origin and autoreactivity of antibody-secreting cell expansions in acute Systemic Lupus Erythematosus
por: Tipton, Christopher M, et al.
Publicado: (2015)

BNT-162b1: Stevens-Johnson syndrome: case report
Publicado: (2021)

Waning Immunity after the BNT162b2 Vaccine in Israel
por: Goldberg, Yair, et al.
Publicado: (2021)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022)

Acute interstitial nephritis after vaccination with BNT162b2
por: Rieckmann, Sonja, et al.
Publicado: (2022)

Effectiveness of BNT162b2 against COVID-19 in adolescents
por: Powell, Annabel A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o60jvfni5vf4hkfq1rkcq52rbq